Paper
0
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients with Myelodysplastic Syndromes/Neoplasms (MDS): An Analysis from the International Consortium for MDS (icMDS) Validate Database
Authors
Benjamin Rolles,Jan Bewersdorf
Tariq Kewan,Ondřej Bláha,Jessica Stempel,Luca Lanino,Najla Ali,Amy DeZern,Mikkael Sekeres,Geoffrey Uy,Hetty Carraway,Pinkal Desai,Elizabeth Griffiths,Eytan Stein,A. Brunner,Christine McMahon,Rory Shallis,Joshua Zeidner,Michael Savona,Stacey Frumm,Shougat Barua,Namrata Chandhok,Constantine Logothetis,Aram Bidikian,Ted Getz,Gail Roboz,Eunice Wang,Amyah Harris,Maria Amaya,Hayley Hawkins,Somedeb Ball,Justin Grenet,Zhuoer Xie,Yazan Madanat,Yasmin Abaza,Talha Badar,Torsten Haferlach,Jaroslaw Maciejewski,David Sallman,Anoop Enjeti,Kamal Al-Rabi,Khalid Halahleh,Devendra Hiwase,María Díez‐Campelo,David Valcárcel,Claudia Haferlach,Lisa Pleyer,Ιoannis Kotsianidis,Vassiliki Pappa,Valeria Santini,Angela Consagra,Aref Al‐Kali,Seishi Ogawa,Yasuhito Nannya,Matteo Porta,Rami Komrokji,Amer Zeidan,Maximilian Stahl,M.F. Amaya
+57 authors
,María Diez-CampeloJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.